{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T21:20:54Z","timestamp":1784928054991,"version":"3.55.0"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T00:00:00Z","timestamp":1760659200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T00:00:00Z","timestamp":1760659200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82100817"],"award-info":[{"award-number":["82100817"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82270814"],"award-info":[{"award-number":["82270814"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Open Research Fund of Hubei Key Laboratory of Urological Diseases","award":["MNXTJB202412"],"award-info":[{"award-number":["MNXTJB202412"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-025-07172-0","type":"journal-article","created":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T13:14:30Z","timestamp":1760706870000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Pleiotrophin modulates cell proliferation, prostate smooth muscle contraction and fibrosis in hyperplastic prostate"],"prefix":"10.1186","volume":"23","author":[{"given":"Jiang","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiuming","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingzhe","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xun","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiqiao","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muyang","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuming","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianmin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhonghua","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael E.","family":"DiSanto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinhua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0427-2428","authenticated-orcid":false,"given":"Ping","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,17]]},"reference":[{"issue":"2","key":"7172_CR1","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.pop.2019.02.003","volume":"46","author":"RC Langan","year":"2019","unstructured":"Langan RC. Benign prostatic hyperplasia. Prim Care. 2019;46(2):223\u201332.","journal-title":"Prim Care"},{"key":"7172_CR2","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1146\/annurev-med-063014-123902","volume":"67","author":"EH Kim","year":"2016","unstructured":"Kim EH, Larson JA, Andriole GL. Management of benign prostatic hyperplasia. Annu Rev Med. 2016;67:137\u201351.","journal-title":"Annu Rev Med"},{"issue":"16","key":"7172_CR3","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1002\/pros.23702","volume":"78","author":"P Chen","year":"2018","unstructured":"Chen P, et al. Testosterone regulates myosin II isoforms expression and functional activity in the rat prostate. Prostate. 2018;78(16):1283\u201398.","journal-title":"Prostate"},{"key":"7172_CR4","doi-asserted-by":"crossref","unstructured":"Porro C et al. Functional role of Non-Muscle myosin II in microglia: an updated review. Int J Mol Sci. 2021;22(13).","DOI":"10.3390\/ijms22136687"},{"issue":"1","key":"7172_CR5","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1042\/CS20201283","volume":"135","author":"W He","year":"2021","unstructured":"He W, et al. Changes in the expression and functional activities of myosin II isoforms in human hyperplastic prostate. Clin Sci (Lond). 2021;135(1):167\u201383.","journal-title":"Clin Sci (Lond)"},{"issue":"1","key":"7172_CR6","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1111\/jcmm.13345","volume":"22","author":"P Chen","year":"2018","unstructured":"Chen P, et al. The expression and functional activities of smooth muscle myosin and non-muscle myosin isoforms in rat prostate. J Cell Mol Med. 2018;22(1):576\u201388.","journal-title":"J Cell Mol Med"},{"issue":"6","key":"7172_CR7","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/35014065","volume":"2","author":"I Morano","year":"2000","unstructured":"Morano I, et al. Smooth-muscle contraction without smooth-muscle myosin. Nat Cell Biol. 2000;2(6):371\u20135.","journal-title":"Nat Cell Biol"},{"issue":"4","key":"7172_CR8","doi-asserted-by":"publisher","first-page":"F817","DOI":"10.1152\/ajprenal.00602.2015","volume":"311","author":"WA Bushman","year":"2016","unstructured":"Bushman WA, Jerde TJ. The role of prostate inflammation and fibrosis in lower urinary tract symptoms. Am J Physiol Ren Physiol. 2016;311(4):F817\u201321.","journal-title":"Am J Physiol Ren Physiol"},{"issue":"4","key":"7172_CR9","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1172\/JCI108353","volume":"57","author":"PC Walsh","year":"1976","unstructured":"Walsh PC, Wilson JD. The induction of prostatic hypertrophy in the dog with Androstanediol. J Clin Invest. 1976;57(4):1093\u20137.","journal-title":"J Clin Invest"},{"issue":"1","key":"7172_CR10","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/nrurol.2010.207","volume":"8","author":"CK Ho","year":"2011","unstructured":"Ho CK, Habib FK. Estrogen and androgen signaling in the pathogenesis of BPH. Nat Rev Urol. 2011;8(1):29\u201341.","journal-title":"Nat Rev Urol"},{"issue":"1","key":"7172_CR11","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/s10020-023-00734-2","volume":"29","author":"S Shan","year":"2023","unstructured":"Shan S, et al. Mechanism of RhoA regulating benign prostatic hyperplasia: RhoA-ROCK-\u03b2-catenin signaling axis and static & dynamic dual roles. Mol Med. 2023;29(1):139.","journal-title":"Mol Med"},{"issue":"9","key":"7172_CR12","doi-asserted-by":"publisher","first-page":"8605","DOI":"10.18632\/aging.103175","volume":"12","author":"H Xiao","year":"2020","unstructured":"Xiao H, et al. Identification and functional activity of matrix-remodeling associated 5 (MXRA5) in benign hyperplastic prostate. Aging. 2020;12(9):8605\u201321.","journal-title":"Aging"},{"issue":"4988","key":"7172_CR13","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1126\/science.2270483","volume":"250","author":"YS Li","year":"1990","unstructured":"Li YS, et al. Cloning and expression of a developmentally regulated protein that induces mitogenic and neurite outgrowth activity. Science. 1990;250(4988):1690\u20134.","journal-title":"Science"},{"key":"7172_CR14","doi-asserted-by":"publisher","first-page":"1225150","DOI":"10.3389\/fendo.2023.1225150","volume":"14","author":"C Ballesteros-Pla","year":"2023","unstructured":"Ballesteros-Pla C, et al. Pleiotrophin and metabolic disorders: insights into its role in metabolism. Front Endocrinol (Lausanne). 2023;14:1225150.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"7172_CR15","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/bs.acc.2020.02.003","volume":"98","author":"X Wang","year":"2020","unstructured":"Wang X. Pleiotrophin: activity and mechanism. Adv Clin Chem. 2020;98:51\u201389.","journal-title":"Adv Clin Chem"},{"issue":"2","key":"7172_CR16","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1006\/abbi.2001.2705","volume":"397","author":"TF Deuel","year":"2002","unstructured":"Deuel TF, et al. Pleiotrophin: a cytokine with diverse functions and a novel signaling pathway. Arch Biochem Biophys. 2002;397(2):162\u201371.","journal-title":"Arch Biochem Biophys"},{"issue":"12","key":"7172_CR17","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1016\/j.injury.2014.10.013","volume":"45","author":"M Lamprou","year":"2014","unstructured":"Lamprou M, et al. The role of Pleiotrophin in bone repair. Injury. 2014;45(12):1816\u201323.","journal-title":"Injury"},{"issue":"1","key":"7172_CR18","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s12974-017-0823-8","volume":"14","author":"R Fern\u00e1ndez-Calle","year":"2017","unstructured":"Fern\u00e1ndez-Calle R, et al. Pleiotrophin regulates microglia-mediated neuroinflammation. J Neuroinflammation. 2017;14(1):46.","journal-title":"J Neuroinflammation"},{"issue":"4","key":"7172_CR19","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1016\/j.bbrc.2005.09.173","volume":"337","author":"M Antoine","year":"2005","unstructured":"Antoine M, et al. Upregulation of Pleiotrophin expression in rat hepatic stellate cells by PDGF and hypoxia: implications for its role in experimental biliary liver fibrogenesis. Biochem Biophys Res Commun. 2005;337(4):1153\u201364.","journal-title":"Biochem Biophys Res Commun"},{"issue":"11","key":"7172_CR20","doi-asserted-by":"publisher","first-page":"e0207473","DOI":"10.1371\/journal.pone.0207473","volume":"13","author":"J Zhou","year":"2018","unstructured":"Zhou J, et al. A meta-analysis on the role of Pleiotrophin (PTN) as a prognostic factor in cancer. PLoS ONE. 2018;13(11):e0207473.","journal-title":"PLoS ONE"},{"issue":"3","key":"7172_CR21","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1097\/MOH.0b013e3282fdc69e","volume":"15","author":"P Perez-Pinera","year":"2008","unstructured":"Perez-Pinera P, Berenson JR, Deuel TF. Pleiotrophin, a multifunctional angiogenic factor: mechanisms and pathways in normal and pathological angiogenesis. Curr Opin Hematol. 2008;15(3):210\u20134.","journal-title":"Curr Opin Hematol"},{"key":"7172_CR22","doi-asserted-by":"crossref","unstructured":"Xi G et al. Estrogen stimulation of Pleiotrophin enhances osteoblast differentiation and maintains bone mass in IGFBP-2 null mice. Endocrinology. 2020;161(4).","DOI":"10.1210\/endocr\/bqz007"},{"issue":"5","key":"7172_CR23","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/j.cell.2017.07.016","volume":"170","author":"EY Qin","year":"2017","unstructured":"Qin EY, et al. Neural Precursor-Derived Pleiotrophin mediates subventricular zone invasion by glioma. Cell. 2017;170(5):845\u2013e85919.","journal-title":"Cell"},{"issue":"3","key":"7172_CR24","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.cell.2017.04.001","volume":"169","author":"BD Manning","year":"2017","unstructured":"Manning BD, Toker A. AKT\/PKB signaling: navigating the network. Cell. 2017;169(3):381\u2013405.","journal-title":"Cell"},{"issue":"1","key":"7172_CR25","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/s41419-022-04522-4","volume":"13","author":"X Fu","year":"2022","unstructured":"Fu X, et al. Glucose-regulated protein 78 modulates cell growth, epithelial-mesenchymal transition, and oxidative stress in the hyperplastic prostate. Cell Death Dis. 2022;13(1):78.","journal-title":"Cell Death Dis"},{"key":"7172_CR26","doi-asserted-by":"crossref","unstructured":"Porras-Gonz\u00e1lez C et al. Regulation of RhoA\/ROCK and sustained arterial contraction by low cytosolic Ca(2+) levels during prolonged depolarization of arterial smooth muscle. Vascul Pharmacol. 2017;93\u20135:33\u201341.","DOI":"10.1016\/j.vph.2017.05.002"},{"issue":"20","key":"7172_CR27","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.1042\/CS20180294","volume":"132","author":"P Chen","year":"2018","unstructured":"Chen P, et al. Blebbistatin modulates prostatic cell growth and contrapctility through myosin II signaling. Clin Sci (Lond). 2018;132(20):2189\u2013205.","journal-title":"Clin Sci (Lond)"},{"key":"7172_CR28","doi-asserted-by":"publisher","first-page":"110933","DOI":"10.1016\/j.cellsig.2023.110933","volume":"113","author":"J Liu","year":"2024","unstructured":"Liu J, et al. STEAP4 modulates cell proliferation and oxidative stress in benign prostatic hyperplasia. Cell Signal. 2024;113:110933.","journal-title":"Cell Signal"},{"key":"7172_CR29","doi-asserted-by":"publisher","first-page":"403","DOI":"10.3389\/fendo.2018.00403","volume":"9","author":"Z Li","year":"2018","unstructured":"Li Z, et al. Upregulation of Oxytocin receptor in the hyperplastic prostate. Front Endocrinol (Lausanne). 2018;9:403.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"16","key":"7172_CR30","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1002\/pros.24241","volume":"81","author":"D Liu","year":"2021","unstructured":"Liu D, et al. Upregulated bone morphogenetic protein 5 enhances proliferation and epithelial-mesenchymal transition process in benign prostatic hyperplasia via BMP\/Smad signaling pathway. Prostate. 2021;81(16):1435\u201349.","journal-title":"Prostate"},{"issue":"2","key":"7172_CR31","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1002\/pros.20270","volume":"65","author":"M Hatziapostolou","year":"2005","unstructured":"Hatziapostolou M, et al. Heparin affin regulatory peptide is a key player in prostate cancer cell growth and angiogenicity. Prostate. 2005;65(2):151\u20138.","journal-title":"Prostate"},{"issue":"1","key":"7172_CR32","doi-asserted-by":"publisher","first-page":"457","DOI":"10.7314\/APJCP.2013.14.1.457","volume":"14","author":"XY Wang","year":"2013","unstructured":"Wang XY, et al. Meta-analysis of gene expression data identifies causal genes for prostate cancer. Asian Pac J Cancer Prev. 2013;14(1):457\u201361.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"3","key":"7172_CR33","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1002\/pros.21244","volume":"71","author":"B Orr","year":"2011","unstructured":"Orr B, et al. Expression of Pleiotrophin in the prostate is androgen regulated and it functions as an autocrine regulator of mesenchyme and cancer associated fibroblasts and as a paracrine regulator of epithelia. Prostate. 2011;71(3):305\u201317.","journal-title":"Prostate"},{"issue":"11","key":"7172_CR34","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1038\/s41585-018-0087-9","volume":"15","author":"WN Brennen","year":"2018","unstructured":"Brennen WN, Isaacs JT. Mesenchymal stem cells and the embryonic reawakening theory of BPH. Nat Rev Urol. 2018;15(11):703\u201315.","journal-title":"Nat Rev Urol"},{"key":"7172_CR35","doi-asserted-by":"publisher","first-page":"106551","DOI":"10.1016\/j.biocel.2024.106551","volume":"169","author":"L Yang","year":"2024","unstructured":"Yang L, et al. S100A4 modulates cell proliferation, apoptosis and fibrosis in the hyperplastic prostate. Int J Biochem Cell Biol. 2024;169:106551.","journal-title":"Int J Biochem Cell Biol"},{"issue":"4","key":"7172_CR36","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1684\/ecn.2009.0172","volume":"20","author":"E Papadimitriou","year":"2009","unstructured":"Papadimitriou E, et al. Roles of Pleiotrophin in tumor growth and angiogenesis. Eur Cytokine Netw. 2009;20(4):180\u201390.","journal-title":"Eur Cytokine Netw"},{"key":"7172_CR37","first-page":"443","volume":"8","author":"C Gonz\u00e1lez-Castillo","year":"2014","unstructured":"Gonz\u00e1lez-Castillo C, et al. Pleiotrophin as a central nervous system neuromodulator, evidences from the hippocampus. Front Cell Neurosci. 2014;8:443.","journal-title":"Front Cell Neurosci"},{"issue":"11","key":"7172_CR38","doi-asserted-by":"publisher","first-page":"3023","DOI":"10.1111\/jcmm.13213","volume":"21","author":"PS Bai","year":"2017","unstructured":"Bai PS, et al. Pleiotrophin, a target of miR-384, promotes proliferation, metastasis and lipogenesis in HBV-related hepatocellular carcinoma. J Cell Mol Med. 2017;21(11):3023\u201343.","journal-title":"J Cell Mol Med"},{"issue":"1","key":"7172_CR39","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1182\/blood-2006-08-042374","volume":"110","author":"H Chen","year":"2007","unstructured":"Chen H, et al. Pleiotrophin is highly expressed by myeloma cells and promotes myeloma tumor growth. Blood. 2007;110(1):287\u201395.","journal-title":"Blood"},{"issue":"5","key":"7172_CR40","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1111\/cas.13563","volume":"109","author":"G Hu","year":"2018","unstructured":"Hu G, et al. Stomatin-like protein 2 inhibits cisplatin-induced apoptosis through MEK\/ERK signaling and the mitochondrial apoptosis pathway in cervical cancer cells. Cancer Sci. 2018;109(5):1357\u201368.","journal-title":"Cancer Sci"},{"issue":"6835","key":"7172_CR41","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1038\/35077213","volume":"411","author":"GI Evan","year":"2001","unstructured":"Evan GI, Vousden KH. Proliferation, cell cycle and apoptosis in cancer. Nature. 2001;411(6835):342\u20138.","journal-title":"Nature"},{"issue":"1","key":"7172_CR42","doi-asserted-by":"publisher","first-page":"e0115523","DOI":"10.1371\/journal.pone.0115523","volume":"10","author":"X Zhu","year":"2015","unstructured":"Zhu X, et al. The effects of Pleiotrophin in proliferative diabetic retinopathy. PLoS ONE. 2015;10(1):e0115523.","journal-title":"PLoS ONE"},{"issue":"7","key":"7172_CR43","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.7150\/jca.28231","volume":"10","author":"Z Xia","year":"2019","unstructured":"Xia Z, et al. The expression, functions, interactions and prognostic values of PTPRZ1: a review and bioinformatic analysis. J Cancer. 2019;10(7):1663\u201374.","journal-title":"J Cancer"},{"key":"7172_CR44","doi-asserted-by":"publisher","first-page":"15080","DOI":"10.1038\/ncomms15080","volume":"8","author":"Y Shi","year":"2017","unstructured":"Shi Y, et al. Tumour-associated macrophages secrete Pleiotrophin to promote PTPRZ1 signalling in glioblastoma stem cells for tumour growth. Nat Commun. 2017;8:15080.","journal-title":"Nat Commun"},{"issue":"5","key":"7172_CR45","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1002\/glia.23583","volume":"67","author":"N Tanga","year":"2019","unstructured":"Tanga N, et al. The PTN-PTPRZ signal activates the AFAP1L2-dependent PI3K-AKT pathway for oligodendrocyte differentiation: targeted inactivation of PTPRZ activity in mice. Glia. 2019;67(5):967\u201384.","journal-title":"Glia"},{"issue":"5","key":"7172_CR46","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.2741\/4443","volume":"21","author":"H Chen","year":"2016","unstructured":"Chen H, et al. The PI3K\/AKT pathway in the pathogenesis of prostate cancer. Front Biosci (Landmark Ed). 2016;21(5):1084\u201391.","journal-title":"Front Biosci (Landmark Ed)"},{"issue":"9","key":"7172_CR47","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1038\/nrurol.2013.149","volume":"10","author":"JA Rodriguez-Nieves","year":"2013","unstructured":"Rodriguez-Nieves JA, Macoska JA. Prostatic fibrosis, lower urinary tract symptoms, and BPH. Nat Rev Urol. 2013;10(9):546\u201350.","journal-title":"Nat Rev Urol"},{"issue":"4","key":"7172_CR48","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1002\/pros.2990180403","volume":"18","author":"JM Wang","year":"1991","unstructured":"Wang JM, McKenna KE, Lee C. Determination of prostatic secretion in rats: effect of neurotransmitters and testosterone. Prostate. 1991;18(4):289\u2013301.","journal-title":"Prostate"},{"issue":"4","key":"7172_CR49","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1016\/S0022-5347(17)53216-4","volume":"128","author":"S Furuya","year":"1982","unstructured":"Furuya S, et al. Alpha-adrenergic activity and urethral pressure in prostatic zone in benign prostatic hypertrophy. J Urol. 1982;128(4):836\u20139.","journal-title":"J Urol"},{"issue":"1 Pt 1","key":"7172_CR50","doi-asserted-by":"publisher","first-page":"C17","DOI":"10.1152\/ajpcell.1991.261.1.C17","volume":"261","author":"H Gu","year":"1991","unstructured":"Gu H, et al. Rapid increase in inositol phosphate levels in norepinephrine-stimulated vascular smooth muscle. Am J Physiol. 1991;261(1 Pt 1):C17\u201322.","journal-title":"Am J Physiol"},{"issue":"1","key":"7172_CR51","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1006\/dbio.1996.0199","volume":"178","author":"E Szabat","year":"1996","unstructured":"Szabat E, Rauvala H. Role of HB-GAM (heparin-binding growth-associated molecule) in proliferation arrest in cells of the developing rat limb and its expression in the differentiating neuromuscular system. Dev Biol. 1996;178(1):77\u201389.","journal-title":"Dev Biol"},{"issue":"11\u201312","key":"7172_CR52","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.2119\/molmed.2010.00265","volume":"17","author":"JE Bond","year":"2011","unstructured":"Bond JE, et al. Angiotensin-II mediates nonmuscle myosin II activation and expression and contributes to human keloid disease progression. Mol Med. 2011;17(11\u201312):1196\u2013203.","journal-title":"Mol Med"},{"issue":"4","key":"7172_CR53","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1085\/jgp.200208720","volume":"121","author":"M L\u00f6fgren","year":"2003","unstructured":"L\u00f6fgren M, et al. Nonmuscle myosin motor of smooth muscle. J Gen Physiol. 2003;121(4):301\u201310.","journal-title":"J Gen Physiol"},{"issue":"5","key":"7172_CR54","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1523\/JNEUROSCI.2565.04.2005","volume":"25","author":"K Niisato","year":"2005","unstructured":"Niisato K, et al. Age-dependent enhancement of hippocampal long-term potentiation and impairment of Spatial learning through the Rho-associated kinase pathway in protein tyrosine phosphatase receptor type Z-deficient mice. J Neurosci. 2005;25(5):1081\u20138.","journal-title":"J Neurosci"},{"issue":"6 Pt 1","key":"7172_CR55","doi-asserted-by":"publisher","first-page":"2517","DOI":"10.1097\/01.ju.0000085024.47406.6c","volume":"170","author":"RW Rees","year":"2003","unstructured":"Rees RW, et al. Y-27632, a Rho-kinase inhibitor, inhibits proliferation and adrenergic contraction of prostatic smooth muscle cells. J Urol. 2003;170(6 Pt 1):2517\u201322.","journal-title":"J Urol"},{"issue":"3","key":"7172_CR56","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1016\/j.juro.2012.08.220","volume":"189","author":"M Lam","year":"2013","unstructured":"Lam M, Kerr KP, Exintaris B. Involvement of Rho-kinase signaling pathways in nerve evoked and spontaneous contractions of the Guinea pig prostate. J Urol. 2013;189(3):1147\u201354.","journal-title":"J Urol"},{"issue":"1","key":"7172_CR57","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1002\/pros.2990260109","volume":"26","author":"PH Gann","year":"1995","unstructured":"Gann PH, et al. A prospective study of plasma hormone levels, nonhormonal factors, and development of benign prostatic hyperplasia. Prostate. 1995;26(1):40\u20139.","journal-title":"Prostate"},{"issue":"2","key":"7172_CR58","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1002\/pros.20080","volume":"61","author":"RO Roberts","year":"2004","unstructured":"Roberts RO, et al. Serum sex hormones and measures of benign prostatic hyperplasia. Prostate. 2004;61(2):124\u201331.","journal-title":"Prostate"},{"issue":"2","key":"7172_CR59","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1677\/joe.0.1430269","volume":"143","author":"AT Collins","year":"1994","unstructured":"Collins AT, et al. Androgen and oestrogen responsiveness of stromal cells derived from the human hyperplastic prostate: oestrogen regulation of the androgen receptor. J Endocrinol. 1994;143(2):269\u201377.","journal-title":"J Endocrinol"},{"issue":"6","key":"7172_CR60","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/s41419-022-04979-3","volume":"13","author":"Y Yang","year":"2022","unstructured":"Yang Y, et al. Estrogen and G protein-coupled Estrogen receptor accelerate the progression of benign prostatic hyperplasia by inducing prostatic fibrosis. Cell Death Dis. 2022;13(6):533.","journal-title":"Cell Death Dis"},{"issue":"7","key":"7172_CR61","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1038\/s41593-019-0434-z","volume":"22","author":"AM Nikolakopoulou","year":"2019","unstructured":"Nikolakopoulou AM, et al. Pericyte loss leads to circulatory failure and Pleiotrophin depletion causing neuron loss. Nat Neurosci. 2019;22(7):1089\u201398.","journal-title":"Nat Neurosci"},{"issue":"1","key":"7172_CR62","doi-asserted-by":"publisher","first-page":"p575","DOI":"10.1186\/s12967-023-04432-9","volume":"21","author":"Y Li","year":"2023","unstructured":"Li Y, et al. Glutathione peroxidase 3 induced mitochondria-mediated apoptosis via AMPK \/ERK1\/2 pathway and resisted autophagy-related ferroptosis via AMPK\/mTOR pathway in hyperplastic prostate. J Transl Med. 2023;21(1):p575.","journal-title":"J Transl Med"},{"issue":"1","key":"7172_CR63","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/s41420-021-00501-4","volume":"7","author":"J Liu","year":"2021","unstructured":"Liu J, et al. Smoothened Inhibition leads to decreased cell proliferation and suppressed tissue fibrosis in the development of benign prostatic hyperplasia. Cell Death Discov. 2021;7(1):115.","journal-title":"Cell Death Discov"},{"issue":"1","key":"7172_CR64","doi-asserted-by":"publisher","first-page":"13333","DOI":"10.1038\/s41598-017-13831-0","volume":"7","author":"T Skillb\u00e4ck","year":"2017","unstructured":"Skillb\u00e4ck T, et al. A novel quantification-driven proteomic strategy identifies an endogenous peptide of Pleiotrophin as a new biomarker of alzheimer\u2019s disease. Sci Rep. 2017;7(1):13333.","journal-title":"Sci Rep"},{"issue":"26","key":"7172_CR65","doi-asserted-by":"publisher","first-page":"10888","DOI":"10.1073\/pnas.0704366104","volume":"104","author":"Y Chang","year":"2007","unstructured":"Chang Y, et al. Secretion of Pleiotrophin stimulates breast cancer progression through remodeling of the tumor microenvironment. Proc Natl Acad Sci USA. 2007;104(26):10888\u201393.","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-07172-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-025-07172-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-07172-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T14:03:25Z","timestamp":1760709805000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-025-07172-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,17]]},"references-count":65,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7172"],"URL":"https:\/\/doi.org\/10.1186\/s12967-025-07172-0","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,17]]},"assertion":[{"value":"15 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Collection and treatment of all human specimens were carried out in accordance with the approved guidelines of the Ethics Committee at Zhongnan Hospital of Wuhan University. All animal protocols were approved by the Medical Ethics Committee for Experimental animals of Zhongnan Hospital of Wuhan University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have read and agreed to the published version of the manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1128"}}